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Livingorganismsaredependentonaprecise regulationofwaterand sodium.The stabilityof the
internalenvironmentismaintainedthroughaseriesoffeedbackmechanisms,inresponsetochanges
within theorganismaswellas to changes in theexternalenvironment.Manyorgans in thebody
participateinsodiumͲandwaterturnover,butthekidneyistheonlyorganinthebodythatexcretes
orretainssodiumandwaterinaregulatedfashion.Saltretentionisariskfactorinthedevelopment
of hypertension which may lead to renal insufficiency, heart failure and cerebrovascular
catastrophes.Thetraditionalviewhasbeenthathypertensioniscausedbyanexcessoffactorsthat
produce vasoconstriction and sodium retention. This hypothesis has beenmodified after reports
showing thata lowavailabilityofvasodilative,natriuretic factorsalsopredisposes tohypertension.
The precision by which sodium balance is regulated suggests an intricate interaction between
modulatoryfactorsreleasedfromintraͲandextrarenalsources.Intrarenallyproduceddopaminehas
a central role in this interactive network.Dopamine acts as an autocrine and paracrine factor to
inhibit theactivityof renal tubularNa+,K+ͲATPaseaswellasofanumberof tubularsodium influx
pathways. Other natriuretic factors activate the renal dopamine system via a heterologous
recruitmentofdopamineͲ1like(D1R)totheplasmamembrane,whereasdopaminecounteractsthe
effectofantinatriuretic factorsviaunknownmechanisms.Prolactinregulates fluidtransportacross
the plasma membrane by unknown mechanisms.  Prolactin interacts with dopamine in various




thatprolactin inducedaheterologous recruitmentofD1R to theplasmamembrane.These results
suggestthattherenaldopaminesystemhasapermissiveroleforprolactin.Dopamineactingonthe
D1familyofreceptors,andangiotensinII,actingonAT1receptors,exertoppositeeffectsonsodium
excretion. Recent studies have shown that the AT1 receptor and theD1 receptor form a dimer,
where theyactasaunitofopposites.Herewe report that thepowerof theAT1 receptorandD1







has been intensively studied in the past decade, and is generally considered to be an important
indirectmechanism for control of receptor function. To test the concept of allosteric interaction
betweenthe losartanboundAT1receptorandtheD1receptors inan invivomodel,wecompared
theantihypertensiveeffectsof losartanaloneandwithcoͲtreatmentof losartanandaD1receptor
antagonist in rats with experimental hypertension. We found that addition of a D1 receptor
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Theprimaryroleofthekidney istokeepconstancyofthe intraandextracellularmilieu in
the body.Whereas the glomerular filtration rate is rather constantwithin one individual
fromdaytodaytherateoftubulartransportisverycarefullyregulatedtoadjustforchanges
inintake,needsandlosses.
The precision by which sodium balance is regulated suggests an intricate interaction
between modulatory factors released from intraͲ and extrarenal sources. Intrarenally




peptides.Othernatriuretic factorsactivate the renaldopamine systemviaaheterologous












The stability of the internal environment is maintained through a series of feedback
mechanisms, in response to changes within the organism as well as to changes in the
externalenvironment.
Ourbodies aredependenton aprecise regulationofwater and sodium.  The intake and
excretion have to be precise to maintain the body homeostasis. In an adult human,
approximately60%ofthetotalbodyweightconsistsofwater.Thiswaterisdividedintoan
intracellularvolume (ICV)of2/3andanextracellularvolume (ECV)of1/3.Thecontentof






cell shrinkage, andopposite, ICV sodium retention leads to cell swelling and ECV sodium
deficiency.ECVsaltretentionisariskfactorinthedevelopmentofhypertensionwhichmay
leadtorenalinsufficiency,heartfailureandcerebrovascularischemia.Theinternalmilieuis
dependent on the ability of the kidneys to retain or excretewater and sodium, and the
kidneysabilitytoadjustthistothedailyintake.
ThisdistributionofNa+andK+,which isessentialfor life inallorganisms, ismaintainedby,




intracellular ion homeostasis and cellular uptake of nutrition’s like glucose and essential
amino acids, but also its differentiated functions like the propagation of nerve impulses,
musclecontractions,andrenalreabsorptionofsodium.
Tubular reabsorption involves transport of substances across the tubular epithelial cell.
Transporting epithelial cells are polarized i.e. have an apical and a basolateral plasma
membrane.Thesemembranesdifferprimarilywithrespecttothetransporterstheycontain.
















even more astonishing when one considers that the total amount of body water is
approximately42Landthepoolofreadilyexchangeablesodiumisapproximately100g.
Reabsorptionandexcretionofwaterand solutesareperformedby the renal tubules.The
firstpartoftherenaltubulescanbedividedintotwoparts;theproximalconvolutedtubules
and the proximal straight tubules. Themajor part of the filtrate, approximately 67% is







extend from themedullaback to the renal cortex.Theascending loop is impermeable to
waterbutactivelypumpsodiumionsoutofthefiltrateandintotheinterstitium.Thisisthe
driving force for themovement ofwater from the descending limb. The filtrate is then




normally impermeable towater. In the presence of anti diuretic hormone (ADH),water
channels (aquaporins) are transported to theplasmamembraneandwater is reabsorbed
(Nielsenetal.1993,Christensenetal.2000).





To respond to environmental changes, cells must transfer information concerning their
environment across the impermeable plasmamembranes. One solution to this problem
involves three proteins: a receptor that detects information outside the cell, an effector
molecule that alters the intracellular environment and a guanine nucleotide regulatory












theɲͲsubunit.Uponagonistbinding to theGPCR the receptorpromotesaconformational
changeanddissociatesfromGDPandbindstoGTP.ThiswillinduceadissociationoftheGͲ
proteintoanɲandɴ/ɶͲsubunitbothcapableofsignallingandactivatingeffectormolecules.
TheɲͲsubunithasan intrinsicGTPaseactivity,whichwill finally terminate the signalingof
the ɲͲsubunit, however, this activity can be enhanced by a family of proteins called
regulatorsofGproteinsignaling(RGS).Whensignaling isterminatedtheɲͲsubunit isagain
bound to GDP. The GDP bound form of the ɲ subunit has high affinity for ɴ, ɶ, and
reassociationofɲͲGDPwithɴ,ɶreturnsthesystemtothebasalstate(Hepleretal.1992).
The Gɲ is divided into four types; Gɲs/olf, Gɲi, Gɲq/11 and Gɲ12/13. The Gɲs/olf stimulates
adenylatecyclaseandenhancestherateofcAMPsynthesisfromATP.Gɲihavetheopposite
effect, inhibiting adenylate cyclase and thereby cAMP formation. Gɲq/11 stimulates
phospholipaseC,andGɲ12/13isconnectedtoRhosignaling.
AlthoughitiswelldocumentedthatamonomericGPCRactivatesheterotrimericGͲproteins,








Dopaminesignaling ismediatedbyfiveGPCRs inmammals,divided intotwogroupsbased
upon sequence homology, different G protein coupling and thereby different signaling
pathwaysandpharmacologicalprofiles.TheD1receptorgroupconsistsoftheD1andtheD5
receptor. The D2 receptor group consists of the D2, D3 and D4 receptors. The D1 like










was primarily cardiovascular comparisons of the action of dopamine with other amines
(GoldbergLI,1972).





tubular sodium transport by decreasing the activity of tubular Na+, K+ͲATPase in a dose
dependentandreversiblemannerinintactcells(Aperiaetal.1987).
Dopamineisproducedinrenaltubularcellsandtherenalprecursortodopamineisfiltered
LͲdopawhichenters the renal tubularcellviaa sodiumcoupled transporter (Bainesetal.
1980,Hayassietal.1990,SoaresͲdaͲSilvaetal.1994).LͲdopa isconvertedtodopamineby
aromaticaminoaciddecarboxylase (AADC),whichhasbeen localizedalmostexclusively to
theproximaltubules(Hagegeetal.1985,Bertorelloetal.1988).TreatmentwithakidneyͲ
specific LͲdopa analogue (gluͲdopa), results in an increased urinary sodium excretion
associatedwithadecreasedproximal tubularNa+,K+ͲATPaseactivity (Eklöfetal1997)as




Dopamine is metabolized via deamination by mono amino oxidase (MAO) and via
methylationbycatecholͲOͲmethylͲtransferase(COMT)(Kopin1985).Boththeseenzymesare
expressed in the kidney (Fernandes & SoaresͲdaͲSilva 1992). Treatment with the COMT
inhibitor Nitecapone results in increased urinary sodium excretion associated with
decreasedproximaltubularNa+,K+ͲATPaseactivity.Thus,thenatriureticeffectoftherenal
dopamine system ishighlydependenton its capacity tobe regulated in the renal tubular
cell.
Dopamineappearstohaveakeyrole inthe interactiveregulationofrenaltubularsodium
transport, and the signal transduction of dopaminemediated effects on Na+, K+ͲATPase
activity is complex. In the ratproximal tubule,D1Ͳlike receptor signaling is referred tobe
functionaleitheralone(Bainesetal.1992,Chenetal.1993)or inconjugationwithD2Ͳlike
receptors (Bertorello et al. 1990, Satoh et al. 1993). The D1 receptor is generating
downstreammessengersbyactivatingadenelylcyclase,therebygeneratingcAMPfromATP
(Nakajimaetal.1977).cAMPfurtheractivatesproteinkinaseA(PKA)(Bertorelloetal.1991)
which leads to a recruitment of intracellularD1Ͳlike receptors to the plasmamembrane,















evolutionary terms considered as a very ancient hormone.Genes encoding for prolactin,
growthhormone andplacental lactogenevolved from a common ancestral geneby gene
duplication(Nialletal.1971).Whencomparingthecodinggenesequencesofprolactinand
growthhormoneinthesamespecies,apostulationof392millionyearsagowassetforthe
segregation of these two hormones (Cooke et al. 1981). Prolactin is best known as the
hormonethatelicitslactationinmammals.However,ithasbeenfoundtobehighlyversatile
andcanbe found inabroadspectrumof functionssuchasmetabolism, reproductiveand
parenteral behavior, immunoregulation, angiogenesis and osmoregulation. The name
8

prolactin ischosen from its lactating function (Riddleetal.1933).The transcriptionof the










The prolactin receptor is not a GPCR but a single bound cytokine class 1 receptor. The
receptorconsistsofanextracellular,atransmembraneandanintracellulardomain.Several
differentisoformsofprolactinreceptorshavebeendescribed;theseisoformsaretheresult
of different promoters as well as alternative splicing (Hu et al. 1991). The threemajor
membranebound isoformsdescribed in ratsare theshort (291aa), intermediate (393aa)
andlong(591aa)isoforms(Freemanetal.2000).Theextracellulardomainisidenticalinall
threeformsandconsistsofapproximately200aminoacidsthatcanfurtherbedividedinto
two domains of 100 aa each (BoleͲFeysot et al. 1998). The intracellular domain of the
receptor differs in length between these isoforms. Soluble forms of prolactin binding
proteinshavealsobeenfoundinmammaryepithelialcellsandinmilk(Berthonetal.1987,




The activation of the prolactin receptor is initiated by binding of the ligand to the extra
cellular domain of the receptor. The ligand is expressing two binding epitopes for the
receptor, which further results in binding of another receptor molecule, resulting in a
dimerizationanda functionalhomodimericcomplex.Themembraneproximal intracellular
partof thereceptor isconstitutivelyconnected toa tyrosinekinase, Januskinase2 (Jak2).
ActivationofJak2isinitiateduponreceptordimerisation,resultinginatransphosphorylation
withinthecomplex(Ferragetal.1998).Thisresultsinphosphorylationoftyrosineresidues
within the receptor itself (Ruietal.1992).All active formsof theprolactin receptors are
transphosphorylated via Jak2 (Goupille et al. 1997). There are several classical signaling
pathways induced by the prolactin receptor: The Jak/STAT pathway,where Jak proteins




et al. 1994). The Ras/Raf/MAPK pathway (Piccoletti et al. 1994) which transduces
extracellularsignalstothecellnucleusandtherebyactivatinggenesspecificforcellgrowth,
division, differentiation, cell cycle regulation, tissue repair, integrin signaling and cell
migration.Jak2activatesCa2+sensitiveK+channels(Prevarskayaetal.1995),aswellasSrc
and Fyn (Berlanga et al. 1995, alͲSakkaf et al. 1997), which phosphorylates PI3 kinase
(Berlangaetal.1997,Ratovondrahonaetal.1998).
Prolactin regulates fluid andelectrolyte transport across theplasmamembrane.Prolactin
decreasesNa+and increasesK+transport inmammaryepithelialcells(Falconeretal.1983,
1975)Prolactinalso regulates fluid transportacrossamnioticand intestinalepithelialcells
(Mankuetal.1975,Ramseydhetal.1972).
Itiswellknownthatprolactininteractswithdopamineinvarioustissues.Dopamineactsasa
prolactin inhibitory factor inhypothalamus (Dickleyetal.1975,BenͲJonathanetal.2001).







In response to low blood pressure, salt depletion or sympathetic nerve stimulation the
proteolytic enzyme renin is formed in the kidney. Renin has no direct effect on blood
pressure, but converts circulating angiotensinogen, primarily produced in the liver, to







laboratories in Indianapolis, USA (Fasciolo et al. 1938, Page 1935). Angiotensin II is an
endocrine, paracrine, autocrine and intracrine hormone. Angiotensin II constricts the
arterioles and raise blood pressure, it promotes release of aldosterone from the adrenal
gland,which in turn acts in the renal distal tubules and promotes sodium retention and
potassium excretion. Angiotensin II increases the water content in the body via two
mechanisms:1) It isadipsogen,activating thethirstcentre inthehypothalamus,and2) it
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stimulates ADH release from the posterior pituitary gland, resulting in renal water
reabsorption.
Theangiotensin receptorwas identifiedbyLinandGoodfriend in1970 (Lin&Goodfriend,
1970).TheangiotensinreceptorsbelongtothesuperfamilyofGͲproteincoupledreceptors
andarefurtherdividedintoAT1,AT2,AT3andAT4.TheAT1receptoristhemostelucidated
of these four receptors andmediates themajority of all known physiological actions of
angiotensinII.
AT1 signals via several cytoplasmic signaling pathways and interacts with multiple
heterotrimericGͲproteinsincludingGɲq/11,Gɲi/o,Gɲ12andGɲ13.ActivationofGɲq/11activates
phospholipase C and increases cytosolic Ca2+ concentrations, thereby increasing protein
kinase C activity.Gɲi/o inhibits adenylyl cyclase and cAMP production. AT1 also activates
various intracellularproteinkinases includingPKC (Higuchietal.2007).TheAT1 receptor,
like other GͲprotein coupled receptors, has been proposed to undergo spontaneous






1990,Liuetal.1987).Angiotensin II isknown tohaveabiphasiceffecton tubularsodium
reabsorption. Low concentrations, in the picomolar range (10Ͳ12M), increase sodium,
bicarbonate, and fluid reabsorption (Schuster et al. 1984, Liu et al. 1989), while higher
concentrationsinducenatriuresis(Navar1987,Harris1977).AngiotensinIIisalsoknownto
haveabiphasiceffectonproximaltubularNa+,K+ͲATPaseactivity.Picomolarconcentrations
of the hormone increase, whereas micromolar concentrations decrease Na+, K+ͲATPase







ATPhydrolysis. The intracellularsodiumconcentration isnormally in the5Ͳ20mM range,
and Na+, K+ͲATPase activity is stimulated by an increase in intracellular sodium.Na+, K+Ͳ
ATPasemaximumvelocity (Vmax) isachivedat60Ͳ100mMNa+.Thus,Na+,K+ͲATPaseworks





Na+, K+ͲATPasewhich consists of three subunits, ɲ, ɴ and ɶ, is located in the basolateral
plasmamembrane.TheɲͲsubunitisrecognizedasthecatalyticsubunit,bindingsodiumand
ATP in the cytoplasmic domain. The binding sites for potassium and the inhibiting
compounds,digitalisglycosides,arelocatedintheextracellulardomain(Férailleetal.2001).




factors released from intraͲ and extra renal sources. Intra renal produced dopamine and
angiotensinIIactasautocrineandparacrinefactorsregulatingtheactivityofNa+,K+ͲATPase
and thesodium influxpathways.Theantinatriureticeffectsofangiotensin IIaswellasof
noradrenalin acting on DͲadrenercic receptors are opposed by dopamine. Short term
exposureofaD1Ragonistresults in internalizationofA1Randacompleteabolishmentof
A1R signaling,whileexposurewithangiotensin II results in internalizationof theD1Rand
abolishment of D1 receptor signaling (Khan et al. 2008). The effect of atrial natriuretic
peptide, nitric oxide and noradrenaline acting on EͲadrenergic receptors (EͲAR), are
dependentonanintactrenaldopaminesystem(Holtbäcketal.2000,Venkatakrishnanetal.
2000,Brismaretal.2002).During inhibitionofthe intrarenaldopaminesynthesisor inthe
presenceofD1R antagonist thesenatriuretic factorshavenoeffecton renal saltbalance
regulation.  These effects are explained by heterologous D1R recruitment to the plasma
membrane.
Takentogether,dopaminecoordinatestheeffectsofantinatriureticandnatriureticfactors.




Blood pressure is the product of cardiac output and the vascular resistance. It is highest
when the heart contracts; the systolic pressure, and lowest between contraction; the
diastolicpressure.Thusbloodpressureincreasesduetoanincreaseinthecardiacoutput,an
increaseinvascularresistance,oracombinationofthetwo.
Hypertension is the single leading risk factorpredisposing toheartattack, cerebral stroke
and renal failure. Identified causes to high blood pressure are referred to as secondary




transporters or in proteins regulating tubular sodium transport (Wilson et al. 2003),
however,mostpatientswithhypertension (>90%)havehighbloodpressureofunknown
causesi.e.essentialhypertension.
Arterial blood pressure is regulated by several interrelated systems.Neural regulators of
bloodpressureactveryfasttocorrectacuteabnormalitiesinbloodpressure,butlosetheir
effects within hours to days. Hormonal induced vasoconstriction by norepinehrineͲ
epinephrineprovidesmoderately rapid controlof arterialbloodpressure. Themain longͲ
termregulatorofbloodpressureisthesodiumtransportsysteminthekidney.

Guyton described in 1987 the relationship between blood pressure (BP) and sodium
excretionasthepressure–natriuresiscurve (Guyton1987). Increase inBPcauses increased
natriuresis in order to return the BP to normal. However, impairments in the pressure–
natriuresis relationship cause a rightward shift in the curve necessitating increased BP in
ordertorestorethebloodvolume.

The traditional view has been that hypertension is caused by an excess of factors that
produce vasoconstriction and sodium retention. The twomost obvious candidates have
been noradrenalin and angiotensin II. This hypothesis has been modified after reports
showing that a low availability of vasodilative, natriuretic factors also predisposes to
hypertension. Several lines of evidence suggest that dopamine has a role in the
pathophysiology of hypertension. Clinical studies in patients with essential hypertension
have shown dysregulations in dopamine formation, attenuated natriuretic response to
dopamine and adefectiveD1 receptor coupling (Harvey etal.1984, Sanada etal.1999).
Experimentalevidencefortheroleofdopamineinhypertensionisalsopresent.Inratstrains
genetically predisposed to develop hypertension, similar defects in the renal dopamine
systemarealreadypresentbeforetheonsetoftheincreasedbloodpressure(Kinoshitaetal.
1989,Chenetal.1993).Furthermore,micewithmutationsinanysubclassofthedopamine
receptors or in dopamine signaling proteins develop hypertension (Albrecht et al. 1996,
Asicoetal.1998,Eklöfetal.2001).
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In these studies three strains of ratswere used; 1) SpragueͲDawley, an albino rat strain
extensivelyusedinmedicalresearch,2)Thespontanoushypertensiverat(SHR),inwhichthe
development of hypertension has been associated with a reduced activity in the renal
dopaminesystem(Kawabeetal.1978,Joseetal.1996,Zengetal.2007),and3)theWistarͲ
Kyoto rat, which is the normotensive control rat to SHR. Animals 6Ͳ8 weeks of age,
corresponds to young adult humans,were used. Animals 3weeks of agewere used for
preparationsof renalproximal tubularcells.Allexperimentswereperformedaccording to
Uppsala University and the Karolinska Institutet regulations concerning care and use of
laboratory animals and approved by the Stockholm North ethical evaluation board for













catheterized througha suprapubic incision forurine collection tomeasureurinevolume,
osmolalityaswellassodiumandpotassiumconcentrations.TodeterminetheGFRaringer
solution containing [3H]ͲmethoxyͲinulin was administered, initially as a bolus injection
containing4ʅCifollowedbyacontinousinfusionof2ʅCiper100gbodyweight.

Theexperimentwasdivided into6collectionperiodsof20minuteseach; the first twoas





Ratsweredivided into threegroups.Group1 (prolactin):animals receivedan intravenous
bolus injection of 0.3 IU prolactin followed by continuous infusion of 3 IU/hour/kg body
weight during the four experimental sampling periods. Group 2 (vehicle): infusions and
samplingswereidenticaltotheprolactintreatedanimalsexceptthatprolactinwasomitted.
Group3 (prolactinandD1Rantagonist):animalsreceived thesameprolactin treatmentas






















subjected to ether anesthesia in an ad hoc chamber.Abdominal aorta, proximal to renal
arterieswasvisualizedthroughabdominalleftflankincision.Thevagusnervewasseparated
andasilk ligaturewet inglycerolwasplacedaroundtheaorta.Aprobewasplacedonthe
aorta and the ligature was tied around it. Once the tight was secured, the probe was




regularwaterandgroup2 (losartan) receiving20mg losartanperkg/day in theirdrinking
water. At the beginning of thirdweek: seven of the losartan treated animals started to






weighted and catheters were inserted into the carotid and right femoral arteries for
recordingofmean arterialpressureusing a Statham transducer. Thedepthof anesthesia






studies on proximal tubular Na+, K+ͲATPase activity was performed. The Na+, K+ͲATPase
activity was determined as ouabain sensitive ATP hydrolysis in microdissected proximal




To exclude ATP hydrolysis originating from other ATPͲases, one part of the preparations
were incubated with the Na+, K+ͲATPase inhibitor ouabain. Measurements of ouabain
incubatedtubuleswerealwaysperformed inparalleltotheexperimentaltubules.Foreach
group per experiment five to eight tubular segments were measured. The result was
calculated as the difference between the mean value for total ATPase and ouabainͲ
insensitiveATPaseactivity,andgivenasabsolutevalues.

Experimental procedure   The experimental kidneywas perfused in vivowith a solution
containing0.05%collagenaseand0.1%serumalbumin.Thekidneywasthenremovedand
cutalongthecorticopapiallyaxisintosmallpyramids.Thesepreparationswereincubatedfor
20minutes in a solution containing 0.05% collagenase todisrupt the supporting collagen
surroundingthetubules.Themitochondrialrespirationinthepreparationswasoptimizedby
addingbutyrateandoxygenduring the incubationperiod.After incubation, the tissuewas
rinsed inasolutioncontainingthesamecompositionastheperfusionsolutionexceptthat
collagenase, calcium and serum albuminwereomitted. Single proximal tubular segments
were thenmanuallydissected from theouter renal cortexusinga stereomicroscope, fine
needles and mouthͲpipetting. Length determinations of tubules were performed by
transferring an individual tubule to a bacteriological glass slide to be photographed. The







1 ʅgwas used. Since amaximal responsewas found at 1 ʅg/ml this concentrationwas
further used in studies of the signaling pathways. Previous studies have shown a dose
dependent effect of dopamine in the range between 10Ͳ7M to 10Ͳ4M, with a maximal
responseat10Ͳ4Mat30min incubation (Aperiaetal.1987). In this studydopaminewas
used at the concentration of 10Ͳ5M. Inhibitors of the intra renal dopamine production;
benserazide (10Ͳ5M)andcarbidopa (5x10Ͳ4M)wereaddedtothemicrodissectedtubules in
thedissection solution 30minbefore treatment.Dopamine receptor agonists SCH 23390
(10Ͳ6M)andraclopride(10Ͳ6M)wereadded10minutesbeforetreatment.Concentrationsof
these drugswere selected on the basis of previous studies (SoaresͲdaͲSilva et al. 1998,
Grenaderetal.1991,Holtbäcketal.1999,Edwardsetal.2001).ThePKAinhibitor:H89(3x
10Ͳ5M),PKCinhibitor:bisindolylmaleicacid(BIM)(10Ͳ6M),PI3Ͳkinaseinhibitor:wortmannin




room temperature,either inmicrodissection solution (controle tubules)orwith indicated
compounds(experimentaltubules).
TrisͲATP,and ɶͲ[32P]ͲATPwereadded to the tubules,whichweremadepermeableby fast
freezing and thawing, giving ATP and sodium free access into the cell. Tubules were






Western blot is an antiͲbody based technique used to detect specific proteins in a given
sampleoftissuehomogenateorextract.Electrophoresisisusedtoseparatedenaturatedor
native proteins by the length of the polypeptide (denaturated condition) or by the 3
dimensionalstructureoftheprotein(native/nonͲdenauratingconditions).Thewesternblot
techniqueisformanyprotocolsthefinalstepbywhichtheresultisreceived,thisalsoapply








attached to a solid substrate; this was performed by using sepharoseͲG. The proteinͲ
antibodyͲcomplexwas thenpossible toprecipitate from therestof thehomogenateusing
centrifugation. Tominimize unspecific binding in the homogenate to sepharoseͲG, a preͲ
clearing stepwas performed. The homogenatewas incubatedwith sepharoseͲG for one








Experimental procedure   Rat renal cortical sliceswere treatedwith indicated drugs and
incubationtimes.Treatmentwasstoppedbyaspiratingthetreatmentbufferandsliceswere
immediately frozen. Slices were thawed and homogenized in a ripa buffer (pH 7.4)
containingprotease inhibitors topreventproteindegradation.The resultinghomogenates
were centrifuged for a short time at low speed to get rid of cell debris. Protein
concentrations in the resulting supernatants were adjusted to equal amount between
samples.ThehomogenateswerethensubjectedtoaclearingͲstepwithsepharoseͲGforone
hour, followed by the precipitating antibody for another hour at 4϶C using end to end
turning. The homogenateͲantibodymixtureswere further subjected to sepharoseͲG over
nightusingendtoendturningat4϶C.ProteinswereelutedwithLaemmlibuffer,heatedto
59Ͳ70°Cfor15min,andresolvedbyWesternblot.
Biotinylation was used to detect changes in dopamine receptor abundance at the cell
surface in intact proximal tubular cells and HEK 293 cells. Biotin binds covalently to all
exposedproteins,whichenablesseparationof theseproteins fromcytosolicproteins.The
bindingisrapidandunlikelytodisturbthenaturalfunctionofthemoleculeduetothesmall
size of the biotin molecule (244 Da). The biotinylated proteins are further bound to





Experimental procedures Proximal tubular cells were treated in the presence and the
absence of prolactin at a final concentration of 1μg/ml for 10minutes at 37϶C. Surface
membraneproteinswerebiotinylatedbyexposingcellstoEZͲlinkedSulfoͲNHSͲSSBiotinata
final concentration of 1mg/ml in PBS at 4°C for 2 hours. Cells were rinsed, lysed and
centrifugedat14,000xgfor10minat4°C.Thesupernatantswereadjustedtoequalprotein
amountsbetween samples.Biotinylatedproteinswere capturedwith streptavidinͲagarose
beadsovernightat4°CusingendͲtoͲendmixing.ProteinswereelutedwithLaemmlibuffer,
heatedto70°Cfor15min,andresolvedbyWesternblot.
To study the effect of losartan in renal proximal tubular cells or inHEK 293 cells double
transfectedwithD1RandAT1R,biotinylationtechniqueswereperformed.Cellsweretreated
inthepresenceandtheabsenceoflosartan(10Ͳ5M)inaKrebsbufferfor20min.Cellsurface
proteins were biotinylated using EZ linked SulfoͲNHSͲSS Biotin in PBS, at a final
concentrationof1mg/mlat4϶C for2hours,duringgentlyshaking.Cellswere rinsedand
homogenized inabuffer containing sucrose (320mM).Homogenateswerecentrifugedat
800xgfor5min,andsupernatantswerecollected.Proteinconcentrationswereadjustedto
equalamount.Supernatantsweresubjectedtocentrifugationat10.000xgfor20min.The
resulting pellets were resuspended and proteins were adjusted to equal concentration.
BiotinylatedproteinswerecapturedwithstreptavidinͲagarosebeadsfor2hoursat4oCusing
end to end turning. Proteinswere recovered by centrifugation,washed and elutedwith
Laemmlisamplebuffer,heatedto70oCfor15minutesandresolvedbyWesternblot.
Subcellular fractionationDopamine receptorabundancewas studied in thepresenceand




protein composition allow them to be separated from othermolecular components and
organelles(Linetal.2009).Separationoftheplasmamembraneandcytosolicproteinswere
performedby centrifugation. The presence of dopamine receptorswere examined in the
plasmamembranefraction(Na+,K+ͲATPaseenriched)andcytosolicfraction(Na+,K+ͲATPase
nonenriched)inthepresenceandtheabsenceofprolactin.
ExperimentalprocedureRenal cortical sliceswere incubatedwithprolactin (1μg/ml). The
treatmentwas stopped by a rapid freezing procedure on dry ice. The renal sliceswere
homogenizedinasucrosebasedbuffer(250mM)containingproteaseinhibitors,followedby
ashortlowspeedcentrifugationtoremovecelldebrisandwholecells.Thesupernatantwas









energy at a different specific wavelength. The protein of interest and the fluorescent
moleculeareconjugatedinaconstructwhichmakesdetectionofthereͲemittedsignalfrom
the proteinͲfluorescentmolecule possible. Two different fluorophores were used in this
study; Venus and CFP. To detect the signals from the constructs a Zeiss LSM 510 laser
scanningconfocalmicroscopewasused.Aconfocalmicroscopeusespointilluminationanda
pinhole in an optically conjugate plane in front of the detector to eliminate out of focus
signal.Sincethemajorityofthelightfromsamplefluoresenceisblockedatthepinhole,long
exposure timesareoften required. Increasing illumination increases the rateatwhich the
fluorophores bleach, limiting the duration of the experiment. It is therefore generally
preferable touse theminimumpossible illumination intensity toavoidbleaching (Yuste&
Konnerth,Coldspringharborlaboratorypress.2005).

Experimental procedure Full length constructs of D1R and AT1Rweremade; pD1RͲCFP,
pD1RͲVenus,pAT1aRͲCFPandpDESTͲrAT1aRͲVenus.Amutated formofD1Rwithin theCͲ
terminuswasalsoperformed.This formhasserinsatpositions397and398mutated into
alaninsby cDNA sitedirectedmutagenesis technique (U.S.E.Mutagenesis kit). The amino
acidsS397/398areknowntobeofcriticalimportancetointeractionbetweenD1RandAT1R
(Khan etal.2008). Structureof all constructswas verifiedusingBigDye®Terminator v3.1
CycleSequencingKit(AppliedBiosystems).

SpragueͲDawley rats,3weeksold,wereused forpreparationofprimaryculturesof renal
proximal tubular cells. Cells were cultured in supplemented Dulbecco'smodified Eagle's
medium(Gibco31600)containing10%FBS,on25mmglasscoverslipsfor48hin5%CO2at




all double transfections were performed at 1:1 ratio. Transfection of HEK293a was
performed using Exgene 500, which is based on internalization of nucleic acids by








witha40x (1.2NA,water)objective.Emissionwas inducedwith laser linesat514nmand
485nm.Detectionwasperformedusing LP 530 andBP47Ͳ500 filters forVenus andCFP
labels,respectively.Cellswithlowtomediumstrongfluorescencewereselectedforfurther
studies. Imageswere collected before treatment, after 5 and 10minutes or 20 and 30
minutesoftreatment.Foreachtimepointatleast16cellswereanalyzed.Themembraneto
cytosolratiowascalculatedbydividingtheaverageintensityofanareaintheregionofthe







Cyclic adenosine monophosphate (cAMP) is synthesized from ATP by adenelyl cyclase.
Adenelylcyclase is locatedatthe innersideoftheplasmamembranewhere itrespondsto
Gɲ proteins, either stimulatory (Gɲs) or inhibitory (Gɲi). D1R is known to be positively
coupled toGɲSwhich activatesadenelyl cyclaseandenhances cAMPproduction.AT1R is
knowntobenegativelycoupledtoadenelylcyclaseviaGɲiwhichresults inareductionof
cAMP.Measurement of cAMPwas performed by using an enzymatic immunoassay. This
methodusesquantitativedeterminationofcAMPviaapolyclonalantibodywhichinducesa




cAMP in lymphomacells isapproximately8minutes(Barberetal.1988).Topreventbreak




Experimental procedure SpragueͲDawley rats, 3weeks old,were used for preparation of
primary cultures of renal proximal tubular cells. Cells were cultured in supplemented












toaserum freemediumtwohoursbeforetreatment.Cellswereexposedto losartan (10Ͳ5
M),theD1receptoragonistSKFͲ38393(10Ͳ5M)orvehicleinanoxygenatedbuffercontaining
3ͲisobutylͲ1Ͳmethylxanthine(IBMX)(0.5ʅM)for20minutesat37϶C.Aftertreatment,cells












of transcriptionanddifferentgene splicing. In rodentsone longand three short isoforms
havepreviouslybeendescribed(BoleͲFeysotetal.1998,Alietal.1991).Weconfirmedthe
presenceofprolactin receptors in renal cortical slicesandmicrodissected renalproximal
tubulesbywesternblot.Twoformsofprolactinreceptorsweredetected,one longformof








Prolactin induced a timeͲdependent inhibition of proximal tubularNa+, K+ͲATPase activity
with amaximal inhibitory effect at 15minutes incubation. Prolactin decreased Na+, K+Ͳ














To study a possible interaction between prolactin and the renal dopamine system two
dopaminereceptorantagonistswereused;forthedopamineD1receptor(SCH23390,10о6
M)and for thedopamineD2 receptor (raclopride,10о6M). In tubulespretreatedwith the
D2R antagonist, prolactin still inhibitedNa+, K+ͲATPase activity. In contrast,when tubules
were preincubated with the dopamine D1 receptor antagonist the inhibitory effect of





Wecontinuedbyexamine theabilityofprolactin to reduceNa+,K+ͲATPaseactivityduring
inhibitionofrenaldopamineproduction.Twodifferentinhibitorsoftheintrarenaldopamine
production were used. Renal slices were preincubated with the aromatic amino acid
carboxylase (AADC) inhibitors; benserazide (10Ͳ5 M) or carbidopa (5x10Ͳ4 M) before









treated intravenously with luteotropic hormone isolated from sheep pituitary glands.
Prolactin induced an increase inurinary sodiumexcretion inevery rat. The responsewas
variablewitha9.1±3.8Ͳfoldincreaseinurinarysodiumexcretion.Thiseffectwasassociated
withanapproximatetwofoldincreaseinurinaryflowrateandurinarypotassiumexcretion.






The achieved plasma prolactin concentration during the present experiments can be
estimatedto400ngpermlbasedondataof(Stieretal.1984)wheretheratsreceivedthe
same doses of prolactin and the plasma levels were measured. This approximates the
elevatedplasmaprolactinlevelsfoundduringestrusandlactation(HardmanJEetal.2001).
Assumingthatthenativehormone,ratprolactin, isaspotentasovineprolactin,the levels
achieved in thecurrentexperimentsmaybeconsistentwithphysiologic levelsunder such
conditions. The same levelsofprolactin can alsobe seenduring antipsychotic treatment.
During chlorpromazine therapy, serumprolactin concentration increases toapproximately
400ngperml (RangHPetal.1999).Thesedata implythattheresultsmayberelevant in
physiologic conditions in females and during antipsychotic treatment in both men and
women.TheD1receptorantagonisttreatedratsshowedasmallincreaseinurineosmolality.










6M).When added alone, neitherH89 norBIM had any significant effect on theNa+, K+Ͳ















ATPasewas visualized using amonoclonal antibodywhich detects the dephosphorylated
formof SerͲ23 in theNa+,K+ͲATPase ɲͲsubunit (Feschenko& Sweadner1997). In isolated
renalcortical slices,prolactin (1 ʅg/ml) reduced theamountofdephosphorylatedNa+,K+Ͳ
ATPasewithoutanyeffectonthetotalamountofNa+,K+ͲATPase,resultinginasignificantly
reduced ratio between dephosphorylated and total Na+, K+ͲATPase compared to control
(control: 0.93 ± 0.17; PRL 0.27 ± 0.08; P<0.05, n=7).We have previously used the same
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Dopamine and prolactin dose dependently decrease proximal tubular Na+, K+ͲATPase











the plasma membrane, where the receptors become physiologically active. Two
complementarytechniqueswereusedtoexaminewhetherprolactinwasabletorecruitD1
receptorstotheplasmamembrane:subcellularfractionationoftheouterrenalcortexand
cell surface biotinylation, using primary cultured proximal tubular cells.Na+, K+ͲATPase is
generally used as a plasma membrane marker. We confirmed that our subcellular




enriched fraction and reduced in theNa+, K+ͲATPaseͲnonenriched fraction (ratioNa+, K+Ͳ





The hypertensive rat strain SHR has a blunted response to dopamine. This effect can be
attributed todecreasedD1Ͳlike receptor responsiveness (Kinoshitaetal.1989,Zengetal.




Prolactin signaling pathways appear to be identical to dopamine signaling pathways in
proximaltubularcells,includingPKAactivation,PKCphosphorylationoftheɲͲsubunitofNa+,





first performed coͲimmunoprecipitation studies, using the outer 250 μm layer of renal
cortical slices from 40 days old rats. The sliceswere incubatedwith losartan (10Ͳ5M) or
vehicle for 15 minutes. Lysates from these slices were immunoprecipitated with a D1
receptorantibodyoranAT1receptorantibodyrespectivelyandpreparedforWesternblot.
We found, in linewithwhatwehavepreviously reported (Khanetal.2008), that theD1
receptor is coͲimmunoprecipitated with the AT1 receptor, and vice versa. Exposure to




increase in D1 receptors (n=4) (*p < 0.05 vs control). In the opposite direction co






that losartan (10Ͳ5M)significantly increased theabundanceofbiotinylatedD1 receptors in
theplasmamembraneinproximaltubularcellsby13%(n=4)(*p<0.05vscontrol).Asimilar







Cells were transfected with the wild type D1 receptor and AT1 receptor. Images were
collectedbeforeandat5,10,20and30minutesofexposure to losartan.We found that
30
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To examine whether this effect was dependent on a physical interaction between the
lostartanboundAT1receptorandtheD1receptor,cellsweretransfectedwithwildtypeAT1











To testwhether losartanͲboundAT1 receptorhadanallostericeffecton theD1 receptor,
resultinginD1receptoractivation,werecordedtheeffectoflosartanoncAMPgenerationin
proximaltubularcells,whichexpressrelativelyhighlevelsofendogenousAT1receptorsand
D1 receptors.We found that losartan significantly increased cAMP in these cells by 38%
(n=7)(*p<0.01vscontrol).NextwerecordedtheeffectoflosartanoncAMPgenerationin
HEK 293a cells, double transfectedwith theAT1 receptor and theD1 receptor. Losartan
significantly increasedcAMP in thesecellsby27% (n=10) (*p<0.001vscontrol).Losartan
did not have any effect on cAMP in cells single transfectedwith theAT1 receptor orD1
receptoralone.

Toexaminewhether the cAMP generatingeffectof losartan requiredphysical interaction
between theAT1receptorand theD1receptor,cellsweretransfectedwithwild typeAT1
receptorandmutantD1receptor(S397A/S398A).LosartandidnothaveanyeffectoncAMP
productioninHEK293acellstransfectedwiththeAT1receptorandtheD1receptormutant.
To confirm the functionality of the mutant D1 receptor, transfection of HEK cells with




Hypertension was generated by performing a surgical procedure that leads to aortic
coarctationproximaltotherenalartery.Inthecontrolgroup(n=3)14daysafterthesurgical
procedurean increasedbloodpressureproximal to thecoarctationwasrecorded (carotid)
144±3,8mmHg, anddistal to the coarctation (femoral)by106,7±14,8mmHg.  In rats
treatedwith losartan (20mg/kg/day) (n=5) day 7 to 14 after the surgical procedure, the
pressure proximal to the coarctation was 105 ±9 mmHg. Addition of a D1 receptor

































al. 2002). Prolactin has been shown to regulate fluid transport across cells in several
different tissues, but relatively little information is available on its effects on renal ion









Na+ 20mmol/L,which is the approximatenormal intracellularNa+ concentration in renal
proximaltubularcells.Theeffectsofprolactin,boththeinvivoandtheinvitroeffects,were
abolished by a D1R antagonist. The LͲdopa level in micro dissected proximal tubular
segmentsishighenoughtoproducedopamine(Ibarraetal.1996).

We found that prolactin signaling pathways appear to be similar to dopamine signaling
pathways in the proximal tubule. Subthreshold doses of prolactin and dopamine had a
synergistic effect, and prolactin induced a heterologous recruitment of D1Ͳlike receptors
fromtheinteriorofthecellintotheplasmamembrane.DopaminemediatesbothPKAͲand
PKCͲdependentphosphorylationofthecatalyticɲͲsubunitofNa+,K+ͲATPase(Bertorelloetal.
1989, Fisone et al. 1994, Gomes et al. 2002). PKAͲinduced phosphorylation of SerͲ943
enhancesPKCͲinduced inhibitionofNa+,K+ͲATPaseactivity(Chengetal.1997). Inaddition,
dopamineͲinduced inhibition of Na+, K+ͲATPase includes an activation of PI 3ͲK and a
dimerizationwithNa+,K+ͲATPase(Chibalinetal.1998,Yudowskietal.2000).BesidesJAKͲ2
activation,prolactinanddopamineseemtosignalviasimilarpathwaysintherenalproximal
tubule.Whetheroneormoreof the JAKͲ2Ͳphosphorylatedproteinsparticipate inD1Ͳlike
receptorrecruitmenttotheplasmamembraneisaninterestingtopicforfurtherstudies.

In vivo treatment of SpragueͲDawley ratswith prolactin resulted in a dramatic nine fold
increase in urinary sodium excretion,without any effect on glomerular filtration rate or
bloodpressure.Thisnatriureticresponsewasassociatedwithkaliuresis,suggestingthatthe
proximaltubuleisthemajorsiteofactionofprolactin.Prolactintreatmenthadnosignificant
effectsonGFRorbloodpressure.We found that the renal effectsofprolactin, including




wasblunted inspontaneoushypertensive rats.The lackofprolactineffect inspontaneous
hypertensiveratsemphasizestheroleofprolactin interactingwithdopaminebutdoesnot














that the AT1 receptor and the D1 receptor form a dimer, where they act as a unit of
opposites (Khan et al. 2008). The results from the coͲimmunoprecipitation studieswere
compatiblewiththenotionthattheD1receptorandtheAT1receptorformaheterodimer.
Interestingly,agonistandantagonistbindingtotheAT1receptorhadoppositeeffectsonthe
AT1 receptorͲD1 receptor heteromeric complex. Results from a previous study have
indicated that the power of interaction between the AT1 receptor and D1 receptor is




receptor, serine397and serine398, tobeofcritical importance forD1 receptorandAT1
receptor interaction.HereweusedtransfectedHEKcellstotestwhethertheAT1receptor
might increase the surface expression ofmutant D1 receptors that lacked themotif of
importance for the interactionwith theAT1 receptor. SurfaceexpressionofD1 receptors
was not increased in these cells andwe conclude that the effect of losartanͲbound AT1
receptorsonD1receptorplasmamembraneexpressioncanbeattributedtothefunctionof
the AT1 receptorͲD1 receptor heterodimer. The losartan triggered increase in plasma







triggered by losartan. The finding that losartan failed to increase plasma membrane
expression of themutant D1 receptor, that does not form a heterodimerwith the AT1










allosteric effects on its protomer, theD1 receptor, resulting in activation ofD1 receptor
signaling. Allostericmodulationwithin aheterodimer,where a structuralmodification in
one protomer will affect the structure and function of the other protomer, has been
intensively studied in the past decade, and is generally considered to be an important
indirect mechanism for control of receptor function. Allosteric modulation among
heterodimericGPCRs,wherebyagonistactionsatonememberofaheterodimer influences
functional coupling of the other protomer, has been demonstrated for many GPCRSs,




theD1receptor inan invivomodel,wecomparedtheantihypertensiveeffectsof losartan
alonewithcoͲtreatmentoflosartanandaD1receptorantagonistinratswithexperimental





Many natriuretic factors, including atrial natriuretic peptide and nitric oxide exert their
effectviatherenaldopaminesystem.Heterologusreceptorrecruitment isoneexplanation
for this effect. We used two complementary techniques, subcellular fractionation and
biotinylation toexamine theeffectofprolactin inplasmamembraneexpressionof theD1
receptor.We found that prolactin significantly increased D1 receptors inserted into the
plasma membrane. The basal level of prolactin is elevated during pregnancy and after




al. 1999). Prolactin induces transcription of several different genes, both by positive and
negativeregulation.Isthistranscriptionalteredorenhancedininfantsreceivingadifferent
amountofprolactin,andifso,shouldprolactinbeafactorinconsiderationwhenproducing
baby formula. The infant does not have the ability to regulate sodium excretion or
preservation as older children and adults, by having a blunted response to hormonal
regulation. Speculatively Ͳ the maturation of this ability may be affected by an early




thatwhile circulating angiotensin II levels exert direct effects on vascular resistance, the
circulatinglevelsofdopaminearetoolowtoplayaphysiologicalorpathoͲphysiologicalrole.
The current study was performed on renal tubular cells that play a central role in the
regulationofsaltbalance,andindirectly,inbloodpressureregulation.Willtheresultsfrom
thisstudybeapplicableforothertissues? Thus itshouldbeof importancetoexaminethe
role of the AT1 receptorͲ D1 receptor complex in other cells of importance for cardioͲ
vascularfunctionandbloodpressureregulation,suchasthecardiomyocyte.





more knowledge about the functional significance of receptor heterodimers will
“revolutionizebasic tenetsofpharmacologyand takedrugdevelopment toanew levelof
specificityandefficacy”(Ferréetal.2009).
Totesttheconceptofallosteric interactionbetween losartanboundAT1receptorsandD1
receptors inan invivomodel,wecomparedtheantihypertensiveeffectsof losartanalone
with coͲtreatment of losartan and a D1 receptor antagonist in rats with experimental
hypertension. The results provide proof of principle of a functionally important allosteric
interactionbetweenAT1RandD1RandimplythatattemptsshouldbemadetodeveloplowͲ







Prolactin is a potent natriuretic peptide. This effect is associated with an inhibition of
proximaltubularNa+,K+ͲATPaseactivity.Therenaleffectsofprolactinareabolishedduring
inhibition of the renal dopamine synthesis as well as by a D1 receptor antagonist.We
concludethatdopaminehasacentralroleintheinteractiveregulationofsalthomeostasis.
Not onlyG protein coupled receptors but also a classical tyrosine receptor, theprolactin
receptor, exerts its saltͲregulating effect by heterologous recruitment and an associated
activationofrenalD1receptors.Hypothetically,heterologousreceptorrecruitmentmaybe
one explanation for cross talk between signaling pathwaysmediated by tyrosine kinase
receptorsandGproteinͲcoupledreceptors.Thecurrentstudyconfirmstheconceptthatthe
AT1 receptor and the D1 receptor form a heteromeric signaling complex and identifies
losartan,anAT1receptorantagonistandwidelyusedantihypertensivedrug,asanallosteric
modifier of this complex. The finding that an AT1 receptor antagonist can activate D1
receptor signaling and that this effect is dependent on AT1 receptor and D1 receptor
interactionisnovelandhaspotentialpharmacologicimplications.
In these studieswehave confirmed the central roleof the renaldopamine system in the
regulation of sodium balance. Prolactin induces a natriuretic effect that act via the renal
dopamine systembyheterologous recruitmentofD1 receptors to theplasmamembrane.
EffectsamongdopamineD1receptorsandangiotensinIIAT1receptorsareexplainedbythe
antagonistboundAT1receptorexertinganallostericeffecton itsprotomer,thedopamine
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